METASTATIC SALIVARY GLAND CANCER

This adverse event was reported 36 times

METASTATIC SALIVARY GLAND CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIPTORELIN 4 0.0012
1 LAROTRECTINIB 1 0.0011
2 FLUTAMIDE 1 0.0010
3 BICALUTAMIDE 8 0.0005
4 ONASEMNOGENE ABEPARVOVEC-XIOI 1 0.0004
5 DABRAFENIB 4 0.0002
6 TRAMETINIB 4 0.0002
7 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 1 0.0002
8 VINORELBINE 1 0.0001
9 LAPATINIB 2 0.0001
See all drugs enriched for association with METASTATIC SALIVARY GLAND CANCER